[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334763-105":59,"doc-detail-334763-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","analysis-of-tumor-associated-axin1-missense-mutations-identifies-variants-that-activate-catenin-signaling","Analysis of Tumor-Associated AXIN1 Missense Mutations Identiﬁes Variants That Activate β-Catenin Signaling","","AXIN1 is a key component of the β-catenin destruction complex and is frequently altered in multiple cancers, especially liver cancer. Truncating AXIN1 mutations produce defective proteins that stabilize β-catenin, yet the functional effects of missense changes remain poorly defined. The study maps critical GSK3β-, β-catenin-, and RGS/APC interaction domains, analyzes 80 tumor-associated variants, and identifies 18 that significantly alter β-catenin signaling. Coimmunoprecipitation and protein-structure analyses explain how domain-specific mutations disrupt binding, destabilize structure, and how truncation length inversely correlates with regulatory function. These findings support functional annotation of AXIN1 alterations and refine which missense variants behave as drivers versus passenger events.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/analysis-of-tumor-associated-axin1-missense-mutations-identifies-variants-that-activate-catenin-signaling/334763/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/analysis-of-tumor-associated-axin1-missense-mutations-identifies-variants-that-activate-catenin-signaling/334763.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does AXIN1 play in β-catenin signaling in normal cells?","Question",{"text":112,"@type":113},"AXIN1 is a scaffold component of the β-catenin destruction complex that helps keep β-catenin levels low. The complex includes APC, AXIN proteins, and kinases such as GSK3β and CK1α.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study evaluate the effects of AXIN1 missense mutations?",{"text":117,"@type":113},"It first identified critical AXIN1 interaction domains and then analyzed 80 tumor-associated variants in those regions. Functional experiments assessed β-catenin signaling, supported by coimmunoprecipitation and comprehensive protein-structure analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportion of tumor-associated AXIN1 missense variants were found to disrupt β-catenin regulation?",{"text":121,"@type":113},"Among 80 analyzed variants, 18 significantly affected β-catenin signaling. The study concludes that most missense variants behave like passenger mutations, while only a subset functionally disrupts the regulatory activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334763,1790012846,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Analysis of Tumor-Associated AXIN1 Missense Mutations Identiﬁes Variants That Activate b-Catenin Signaling  \nRuyi Zhang1, Shanshan Li1, Kelly Schippers1, Yunlong Li1, Boaz Eimers1, Marla Lavrijsen1, Ling Wang1, Guofei Cui2, Xin Chen2, Maikel P. Peppelenbosch1, Joyce H. G. Lebbink3,4, and Ron Smits1  \nABSTRACT  \n◥  \nAXIN1 is a major component of the b-catenin destruction complex and is frequently mutated in various cancer types, particularly liver cancers. Truncating AXIN1 mutations are recognized to encode a defective protein that leads to b-catenin stabilization, but the functional consequences of missense mutations are not well characterized. Here, we ﬁrst identiﬁed the GSK3b, b-catenin, and RGS/APC interaction domains of AXIN1 that are the most critical for proper b-catenin regulation. Analysis of 80 tumorassociated variants in these domains identiﬁed 18 that signiﬁcantly affected b-catenin signaling. Coimmunoprecipitation experiments revealed that most of them lost binding to the binding partner corresponding to the mutated domain. A comprehensive protein structure analysis predicted the consequences of these mutations, which largely overlapped with the observed effects on b-catenin signaling in functional experiments. The structure analysis also predicted that loss-of-function mutations within the RGS/APC interaction domain either directly affected the interface for APC  \nbinding or were located within the hydrophobic core and destabilized the entire structure. In addition, truncated AXIN1 length inversely correlated with the b-catenin regulatory function, with longer proteins retaining more functionality. These analyses suggest that all AXIN1-truncating mutations at least partially affect b-catenin regulation, whereas this is only the case for a subset of missense mutations. Consistently, most colorectal and liver cancers carrying missense variants acquire mutations in other b-catenin regulatory genes such as APC and CTNNB1 . These results will aid the functional annotation of AXIN1 mutations identiﬁed in large-scale sequencing efforts or in individual patients.  \nSigniﬁcance: Characterization of 80 tumor-associated missense variants ofAXIN1 reveals a subset of 18 mutations that disrupt its b-catenin regulatory function, whereas the majority are passenger mutations.  \nIntroduction  \nThe b-catenin signaling pathway is one of the most commonly deregulated pathways among cancers (1) . In normal cells, b-catenin signaling is maintained at low levels by a destruction complex consisting oftheAPC tumor suppressor, scaffold proteins AXIN1, AXIN2, and the kinases GSK3b and CK1a. When cells are exposed to Wnt ligands, activity of this destruction complex is temporarily inhibited, leading to the nuclear translocation of b-catenin. In the nucleus, it associates with members of the TCF/LEF family of transcription factors, thereby regulating the expression of speciﬁc Wnt/b-catenin target genes.  \nIn many tumor types this pathway is constitutively activated through mutational (in)activation of one of the core elements of the destruction complex. For example, in about 70%–80% of colorectal cancers loss-of-function mutations are observed in the APC  \n1Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. 2Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. 3Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. 4Department of Radiotherapy, Erasmus University Medical Center, Rotterdam, the Netherlands.  \nCorresponding Author: Ron Smits, Erasmus MC, Wytemaweg 80, Rotterdam, 3015CN, the [Netherlands. E-mail: m.j.m.smits@erasmusmc.nl](Netherlands. E-mail: m.j.m.smits@erasmusmc.nl)  \n[Cancer Res 2024](Cancer Res 2024);[84:1443](84:1443)–[59](59)  \ndoi: 10.1158/0008-5472 . CAN-23-2268  \nThis open access article is distributed under the Creative Commons At","cbCaikZa5Dnqb5j0","https://ap.wps.com/l/cbCaikZa5Dnqb5j0","pdf",9839307,17,"English","# Abstract\n## Significance\n# Introduction\n## β-catenin pathway and destruction complex\n## AXIN1 and cancer-associated mutations\n## Study aims and approach","[{\"question\":\"What role does AXIN1 play in β-catenin signaling in normal cells?\",\"answer\":\"AXIN1 is a scaffold component of the β-catenin destruction complex that helps keep β-catenin levels low. The complex includes APC, AXIN proteins, and kinases such as GSK3β and CK1α.\"},{\"question\":\"How did the study evaluate the effects of AXIN1 missense mutations?\",\"answer\":\"It first identified critical AXIN1 interaction domains and then analyzed 80 tumor-associated variants in those regions. Functional experiments assessed β-catenin signaling, supported by coimmunoprecipitation and comprehensive protein-structure analyses.\"},{\"question\":\"What proportion of tumor-associated AXIN1 missense variants were found to disrupt β-catenin regulation?\",\"answer\":\"Among 80 analyzed variants, 18 significantly affected β-catenin signaling. The study concludes that most missense variants behave like passenger mutations, while only a subset functionally disrupts the regulatory activity.\"}]","Analysis of Tumor-Associated AXIN1 Missense Mutations Identiﬁes Variants That Activate β-Catenin Signaling | PDF",1790008262,43]